• Organizations: Notal Vision
Pivotal study validates SCANLY Home OCT device for nAMD management
Research

Pivotal study validates SCANLY Home OCT device for nAMD management

New research further supports the clinical performance of Notal Vision's FDA-cleared, AI-based OCT monitoring system for at-home use.
New research supports efficacy of AI in home OCT monitoring
Research

New research supports efficacy of AI in home OCT monitoring

Cross-sectional study results led to the first-ever clearance of an AI algorithm applied to OCT images: Notal Vision’s SCANLY Home OCT.
Notal Vision's at-home OCT for wet AMD demonstrates stable image detection
Research

Notal Vision's at-home OCT for wet AMD demonstrates stable image detection

First-of-its-kind trial on device demonstrates significant reduction in office visits and treatment frequency.
Notal Vision receives FDA De Novo clearance for Scanly Home OCT
Products

Notal Vision receives FDA De Novo clearance for Scanly Home OCT

At-home, self-operated device enables patients to conduct image capturing and monitoring.
Long-term visual outcomes support remote AMD monitoring
Products

Long-term visual outcomes support remote AMD monitoring

Ten-year study reported positive data for Notal Vision’s ForeseeHome program.